Geode Capital Management, LLC Travere Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.26 Trillion
  • Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,842,301 shares of TVTX stock, worth $42.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,842,301
Previous 1,731,045 6.43%
Holding current value
$42.2 Million
Previous $24.2 Million 32.52%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$13.65 - $19.85 $1.52 Million - $2.21 Million
111,256 Added 6.43%
1,842,301 $32.1 Million
Q3 2024

Nov 12, 2024
BUY
$7.89 - $15.21 $510,830 - $984,756
64,744 Added 3.89%
1,731,045 $24.2 Million
Q2 2024

Aug 09, 2024
BUY
$5.26 - $8.28 $554,472 - $872,819
105,413 Added 6.75%
1,666,301 $13.7 Million
Q1 2024

May 13, 2024
BUY
$7.18 - $9.82 $281,154 - $384,531
39,158 Added 2.57%
1,560,888 $12 Million
Q4 2023

Feb 13, 2024
BUY
$5.44 - $9.5 $441,107 - $770,317
81,086 Added 5.63%
1,521,730 $13.7 Million
Q3 2023

Nov 13, 2023
BUY
$7.64 - $17.25 $373,504 - $843,318
48,888 Added 3.51%
1,440,644 $12.9 Million
Q2 2023

Aug 11, 2023
BUY
$15.3 - $22.61 $2.68 Million - $3.96 Million
175,182 Added 14.4%
1,391,756 $21.4 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $2.13 Million - $2.74 Million
119,563 Added 10.9%
1,216,574 $27.4 Million
Q4 2022

Feb 13, 2023
BUY
$18.47 - $26.14 $676,094 - $956,854
36,605 Added 3.45%
1,097,011 $23.1 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $812,869 - $1.02 Million
35,481 Added 3.46%
1,060,406 $26.1 Million
Q2 2022

Aug 12, 2022
SELL
$20.94 - $30.01 $711,478 - $1.02 Million
-33,977 Reduced 3.21%
1,024,925 $24.8 Million
Q1 2022

May 13, 2022
BUY
$23.61 - $30.6 $368,764 - $477,941
15,619 Added 1.5%
1,058,902 $27.3 Million
Q4 2021

Feb 11, 2022
BUY
$24.34 - $31.17 $1.44 Million - $1.85 Million
59,305 Added 6.03%
1,043,283 $32.4 Million
Q3 2021

Nov 12, 2021
SELL
$12.98 - $25.03 $278,563 - $537,168
-21,461 Reduced 2.13%
983,978 $23.9 Million
Q2 2021

Aug 13, 2021
BUY
$14.11 - $26.4 $680,003 - $1.27 Million
48,193 Added 5.03%
1,005,439 $14.7 Million
Q1 2021

May 12, 2021
BUY
$23.37 - $31.77 $4.66 Million - $6.33 Million
199,385 Added 26.31%
957,246 $23.9 Million
Q4 2020

Feb 12, 2021
BUY
$19.17 - $27.87 $14.5 Million - $21.1 Million
757,861 New
757,861 $20.7 Million

Others Institutions Holding TVTX

# of Institutions
213
Shares Held
94M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.47B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email